Alamar Biosciences, Inc. (California) (ALMR)
27.69
-0.99
(-3.45%)
USD |
NASDAQ |
Nov 20, 10:10
Alamar Biosciences Cash from Operations (Quarterly) : -14.73M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -14.73M |
| June 30, 2026 | -11.32M |
| March 31, 2026 | -20.35M |
| Date | Value |
|---|---|
| September 30, 2025 | -14.14M |
| June 30, 2025 | -11.88M |
| March 31, 2025 | -13.07M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Personalis, Inc. | -27.07M |
| 10X Genomics, Inc. | 15.83M |
| Champions Oncology, Inc. | -0.492M |
| Medpace Holdings, Inc. | 216.60M |
| Avantor, Inc. | 195.10M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 11.74M |
| Cash from Financing (Quarterly) | -9.849M |
| Free Cash Flow | -67.04M |
| Free Cash Flow Per Share (Quarterly) | -0.2213 |
| Free Cash Flow to Equity (Quarterly) | -6.318M |
| Free Cash Flow to Firm (Quarterly) | -15.22M |
| Free Cash Flow Yield | -3.49% |